tiprankstipranks
Biolase sees 2023 revenue growth of 15%-20%, consensus $60M
The Fly

Biolase sees 2023 revenue growth of 15%-20%, consensus $60M

Expects to achieve positive adjusted EBITDA results for the second half of 2023.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on BIOL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles